Related Experiment Video
Updated: Aug 7, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death
1Laboratory for Motor System Neurodegeneration, Brain Science Institute, Wako City, Saitama 351-0198, Japan.
Abstract:
X chromosome-linked inhibitor of apoptosis (XIAP) is an endogenous inhibitor of caspase-3, -7, and -9. Smac/DIABLO, an inhibitor of XIAP, is released from mitochondria upon receiving apoptotic stimuli and binds to the BIR2 and BIR3 domains of XIAP, thereby inhibiting its caspase-inhibitory activity. Here we report that a serine protease called HtrA2/Omi is released from mitochondria and inhibits the function of XIAP by direct binding in a similar way to Smac. Moreover, when overexpressed extramitochondrially, HtrA2 induces atypical cell death, which is neither accompanied by a significant increase in caspase activity nor inhibited by caspase inhibitors, including XIAP. A catalytically inactive mutant of HtrA2, however, does not induce cell death. In short, HtrA2 is a Smac-like inhibitor of IAP activity with a serine protease-dependent cell death-inducing activity.
Insights
HtrA2/Omi, a mitochondrial serine protease, inhibits X chromosome-linked inhibitor of apoptosis (XIAP) function by binding. HtrA2 also induces atypical cell death independent of caspase activity.
Area of Science:
- Molecular Biology
- Cell Death Pathways
Background:
- The X chromosome-linked inhibitor of apoptosis (XIAP) protein suppresses apoptosis by inhibiting caspases-3, -7, and -9.
- Mitochondria-released Smac/DIABLO antagonizes XIAP by binding to its BIR2 and BIR3 domains.
Purpose of the Study:
- To investigate the role of the mitochondrial serine protease HtrA2/Omi in regulating XIAP function and inducing cell death.
- To determine if HtrA2/Omi acts as a Smac/DIABLO-like inhibitor of XIAP.
Main Methods:
- Investigated HtrA2/Omi release from mitochondria upon apoptotic stimuli.
- Assessed HtrA2/Omi binding to XIAP.
- Studied the effect of extramitochondrial HtrA2/Omi overexpression on cell death induction.
- Utilized catalytically inactive HtrA2/Omi mutants to assess protease activity dependence.
Main Results:
- HtrA2/Omi is released from mitochondria and directly binds to XIAP, inhibiting its function similarly to Smac/DIABLO.
- Extramitochondrial HtrA2/Omi overexpression induces atypical cell death, independent of caspase activation and resistant to XIAP.
- A catalytically inactive HtrA2/Omi mutant failed to induce cell death, highlighting the requirement of its protease activity.
Conclusions:
- HtrA2/Omi functions as a Smac/DIABLO-like inhibitor of XIAP, antagonizing its anti-apoptotic activity.
- HtrA2/Omi possesses a distinct serine protease-dependent cell death-inducing activity, separate from its XIAP inhibitory function.
Related Concept Videos
Mitochondrial Precursor Proteins
Most of the mitochondrial precursors...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway

